Cargando…

Risk of Suicide After Cancer Diagnosis in England

IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patients with cancers in England and identify risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Henson, Katherine E., Brock, Rachael, Charnock, James, Wickramasinghe, Bethany, Will, Olivia, Pitman, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583458/
https://www.ncbi.nlm.nih.gov/pubmed/30476945
http://dx.doi.org/10.1001/jamapsychiatry.2018.3181
_version_ 1783428439430135808
author Henson, Katherine E.
Brock, Rachael
Charnock, James
Wickramasinghe, Bethany
Will, Olivia
Pitman, Alexandra
author_facet Henson, Katherine E.
Brock, Rachael
Charnock, James
Wickramasinghe, Bethany
Will, Olivia
Pitman, Alexandra
author_sort Henson, Katherine E.
collection PubMed
description IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patients with cancers in England and identify risk factors that may assist in needs-based psychological assessment. DESIGN, SETTING, AND PARTICIPANTS: Population-based study using data from the National Cancer Registration and Analysis Service in England linked to death certification data of 4 722 099 individuals (22 million person-years at risk). Patients (aged 18-99 years) with cancer diagnosed from January 1, 1995, to December 31, 2015, with follow-up until August 31, 2017, were included. EXPOSURES: Diagnosis of malignant tumors, excluding nonmelanoma skin cancer. MAIN OUTCOMES AND MEASURES: All deaths in patients that received a verdict of suicide or an open verdict at the inquest. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated. RESULTS: Of the 4 722 099 patients with cancer, 50.3% were men and 49.7% were women. A total of 3 509 392 patients in the cohort (74.3%) were aged 60 years or older when the diagnosis was made. A total of 2491 patients (1719 men and 772 women) with cancer died by suicide, representing 0.08% of all deaths during the follow-up period. The overall SMR for suicide was 1.20 (95% CI, 1.16-1.25) and the AER per 10 000 person-years was 0.19 (95% CI, 0.15-0.23). The risk was highest among patients with mesothelioma, with a 4.51-fold risk corresponding to 4.20 extra deaths per 10 000 person-years. This risk was followed by pancreatic (3.89-fold), esophageal (2.65-fold), lung (2.57-fold), and stomach (2.20-fold) cancer. Suicide risk was highest in the first 6 months following cancer diagnosis (SMR, 2.74; 95% CI, 2.52-2.98). CONCLUSIONS AND RELEVANCE: Despite low absolute numbers, the elevated risk of suicide in patients with certain cancers is a concern, representing potentially preventable deaths. The increased risk in the first 6 months after diagnosis may indicate an unmet need for psychological support. The findings of this study suggest a need for improved psychological support for all patients with cancer, and attention to modifiable risk factors, such as pain, particularly in specific cancer groups.
format Online
Article
Text
id pubmed-6583458
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-65834582019-07-05 Risk of Suicide After Cancer Diagnosis in England Henson, Katherine E. Brock, Rachael Charnock, James Wickramasinghe, Bethany Will, Olivia Pitman, Alexandra JAMA Psychiatry Original Investigation IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patients with cancers in England and identify risk factors that may assist in needs-based psychological assessment. DESIGN, SETTING, AND PARTICIPANTS: Population-based study using data from the National Cancer Registration and Analysis Service in England linked to death certification data of 4 722 099 individuals (22 million person-years at risk). Patients (aged 18-99 years) with cancer diagnosed from January 1, 1995, to December 31, 2015, with follow-up until August 31, 2017, were included. EXPOSURES: Diagnosis of malignant tumors, excluding nonmelanoma skin cancer. MAIN OUTCOMES AND MEASURES: All deaths in patients that received a verdict of suicide or an open verdict at the inquest. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated. RESULTS: Of the 4 722 099 patients with cancer, 50.3% were men and 49.7% were women. A total of 3 509 392 patients in the cohort (74.3%) were aged 60 years or older when the diagnosis was made. A total of 2491 patients (1719 men and 772 women) with cancer died by suicide, representing 0.08% of all deaths during the follow-up period. The overall SMR for suicide was 1.20 (95% CI, 1.16-1.25) and the AER per 10 000 person-years was 0.19 (95% CI, 0.15-0.23). The risk was highest among patients with mesothelioma, with a 4.51-fold risk corresponding to 4.20 extra deaths per 10 000 person-years. This risk was followed by pancreatic (3.89-fold), esophageal (2.65-fold), lung (2.57-fold), and stomach (2.20-fold) cancer. Suicide risk was highest in the first 6 months following cancer diagnosis (SMR, 2.74; 95% CI, 2.52-2.98). CONCLUSIONS AND RELEVANCE: Despite low absolute numbers, the elevated risk of suicide in patients with certain cancers is a concern, representing potentially preventable deaths. The increased risk in the first 6 months after diagnosis may indicate an unmet need for psychological support. The findings of this study suggest a need for improved psychological support for all patients with cancer, and attention to modifiable risk factors, such as pain, particularly in specific cancer groups. American Medical Association 2018-11-21 2019-01 /pmc/articles/PMC6583458/ /pubmed/30476945 http://dx.doi.org/10.1001/jamapsychiatry.2018.3181 Text en Copyright 2018 Henson KE et al. JAMA Psychiatry. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Henson, Katherine E.
Brock, Rachael
Charnock, James
Wickramasinghe, Bethany
Will, Olivia
Pitman, Alexandra
Risk of Suicide After Cancer Diagnosis in England
title Risk of Suicide After Cancer Diagnosis in England
title_full Risk of Suicide After Cancer Diagnosis in England
title_fullStr Risk of Suicide After Cancer Diagnosis in England
title_full_unstemmed Risk of Suicide After Cancer Diagnosis in England
title_short Risk of Suicide After Cancer Diagnosis in England
title_sort risk of suicide after cancer diagnosis in england
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583458/
https://www.ncbi.nlm.nih.gov/pubmed/30476945
http://dx.doi.org/10.1001/jamapsychiatry.2018.3181
work_keys_str_mv AT hensonkatherinee riskofsuicideaftercancerdiagnosisinengland
AT brockrachael riskofsuicideaftercancerdiagnosisinengland
AT charnockjames riskofsuicideaftercancerdiagnosisinengland
AT wickramasinghebethany riskofsuicideaftercancerdiagnosisinengland
AT willolivia riskofsuicideaftercancerdiagnosisinengland
AT pitmanalexandra riskofsuicideaftercancerdiagnosisinengland